Alimera Sciences (NASDAQ:ALIM) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Alimera Sciences (NASDAQ:ALIM – Get Rating) in a research note released on Friday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued reports about the stock. Craig Hallum dropped their target price on shares of Alimera Sciences from $18.00 to […]